Beta-blockers have beneficial effects even on unclassified cardiomyopathy such as isolated ventricular noncompaction.
Takano
Hiroyuki
H
Komuro
Issei
I
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002227:Carbazoles / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000145:classification / Q000188:drug therapy* / Q000503:physiopathology; D000077261:Carvedilol; D006801:Humans; D011412:Propanolamines / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol